Abstract
AbstractIn this study, the ability of radiomics features extracted from myocardial perfusion imaging with SPECT (MPI-SPECT) was investigated for the prediction of ejection fraction (EF) post-percutaneous coronary intervention (PCI) treatment. A total of 52 patients who had undergone pre-PCI MPI-SPECT were enrolled in this study. After normalization of the images, features were extracted from the left ventricle, initially automatically segmented by k-means and active contour methods, and finally edited and approved by an expert radiologist. More than 1700 2D and 3D radiomics features were extracted from each patient’s scan. A cross-combination of three feature selections and seven classifier methods was implemented. Three classes of no or dis-improvement (class 1), improved EF from 0 to 5% (class 2), and improved EF over 5% (class 3) were predicted by using tenfold cross-validation. Lastly, the models were evaluated based on accuracy, AUC, sensitivity, specificity, precision, and F-score. Neighborhood component analysis (NCA) selected the most predictive feature signatures, including Gabor, first-order, and NGTDM features. Among the classifiers, the best performance was achieved by the fine KNN classifier, which yielded mean accuracy, AUC, sensitivity, specificity, precision, and F-score of 0.84, 0.83, 0.75, 0.87, 0.78, and 0.76, respectively, in 100 iterations of classification, within the 52 patients with 10-fold cross-validation. The MPI-SPECT-based radiomic features are well suited for predicting post-revascularization EF and therefore provide a helpful approach for deciding on the most appropriate treatment.
Funder
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
University of Geneva
Publisher
Springer Science and Business Media LLC
Subject
Computer Science Applications,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference43 articles.
1. Mc Namara K, Alzubaidi H, Jackson JK: Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? Integr Pharm Res Pract. Volume 8:1-11, 2019
2. Okrainec K, Banerjee DK, Eisenberg MJ: Coronary artery disease in the developing world. Am Heart J. 148:7-15, 2004
3. Athappan G, Patvardhan E, Tuzcu ME, Ellis S, Whitlow P, Kapadia SR: Left Main Coronary Artery Stenosis: A Meta-Analysis of Drug-Eluting Stents Versus Coronary Artery Bypass Grafting. JACC Cardiovasc Interv. 6:1219-1230, 2013
4. Chen X, Xin Y, Hu W, Zhao Y, Zhang Z, Zhou Y: Quality of life and outcomes in heart failure patients with ejection fractions in different ranges. PLoS One. 14:e0218983, 2019
5. Authors/Task Force m, et al.: 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 35:2541-2619, 2014